Francesco Rubertis - Profile and Investment Details
Find investors who align with your industry, stage, and vision. Unlock Francesco Rubertis’s full investment profile, including location, investment focus, portfolio companies, and preferences. Sign up today and start building investor relationships that fuel your startup’s growth.
Get connected with all investors today
Social media:
Past investments:
- Gadeta
- SuperX
- Critical Pressure
- Impact Biomedicines
- Inexia
- Aura Biosciences
- Janpix
- Alderaan Biotechnology
- ApcinteX
- Yukin Therapeutics
- Xenikos
- Palladio Biosciences
- Mavalon Therapeutics
- Kymo Therapeutics
- Sydnexis
- Z Factor
- Stealthyx Therapeutics
- Checkmate Pharmaceuticals
- Orexia
- Vaxcyte
- Morphogen-IX
- Phathom Pharmaceuticals
- Diasome Pharmaceuticals
- Capella BioScience
- Divide and Conquer
- Synthorx
- Breakpoint Therapeutics
Investor Profile
Francesco Rubertis is a Venture Capital, Private Equity Firm based in Switzerland with a diverse investment portfolio that includes companies such as Gadeta, SuperX, Critical Pressure, Impact Biomedicines, Inexia, Aura Biosciences, JanpixAlderaan Biotechnology, ApcinteX, Yukin Therapeutics, Xenikos, Palladio Biosciences, Mavalon Therapeutics, Kymo Therapeutics, Sydnexis, Z Factor, Stealthyx Therapeutics, Checkmate Pharmaceuticals, Orexia, Vaxcyte, Morphogen-IX, Phathom Pharmaceuticals, Diasome Pharmaceuticals, Capella BioScience, Divide and Conquer, Synthorx, Breakpoint Therapeutics, . Over time, Francesco Rubertis has demonstrated experience in supporting a range of businesses across various sectors.
While it is not publicly confirmed whether Francesco Rubertis is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.
Startups and entrepreneurs operating in sectors related to Health Care, Hospitals, Women Founded, Biotechnology, Hispanic / Latinx Founded, Productivity Software, Reviews and Recommendations, Logistics, Medical, Therapeutics, App Discovery, Pharmaceuticals may find it worthwhile to explore potential connections with Francesco Rubertis, as their portfolio suggests a familiarity and interest in this area.
Understanding Francesco Rubertis’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.
Angel Match is the easiest way to research investors for your startup so you can spend less time Googling and more time raising.
Find the perfect investors today
